Paper17524501
Pharmacogenomic analyses of targeting the AT-rich malaria parasite genome with AT-specific alkylating drugs.
Woynarowski JM and 2 others. Mol Biochem Parasitol, 2007. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Pharmacogenomic analyses of targeting the AT-rich malaria parasite genome with AT-specific alkylating drugs. Papers, record 17524501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17524501
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacogenomic analyses of targeting the AT-rich malaria parasite genome with AT-specific alkylating drugs.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alkylating Agents | Major topic |
| Antimalarials | Major topic |
| Plasmodium falciparum | Major topic |
| Animals | |
| Base Composition | |
| Benzofurans | |
| Binding Sites | |
| Centromere | |
| Cyclohexanecarboxylic Acids | |
| Cyclohexenes | |
| DNA, Protozoan | |
| Duocarmycins | |
| Genomic Islands | |
| Humans | |
| Indoles | |
| Inhibitory Concentration 50 | |
| Molecular Structure | |
| Parasitic Sensitivity Tests | |
| Pharmacogenetics | |
| Sensitivity and Specificity | |
| Urea |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 17924840 | Genomics-based drug design targets the AT-rich malaria parasite: implications for antiparasite chemotherapy. | https://conductscience.org/library/papers/17924840 |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33198217 | Recent Advances in the Biological Investigation of Organometallic Platinum-Group Metal (Ir, Ru, Rh, Os, Pd, Pt) Complexes as Antimalarial Agents. | Molecules | 2020 | https://conductscience.org/library/papers/33198217 | PubMed |
| 28438976 | Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine. | Infect Immun | 2017 | https://conductscience.org/library/papers/28438976 | PubMed |
| 22459876 | 2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure-activity relationship and mode of action studies. | Eur J Med Chem | 2012 | https://conductscience.org/library/papers/22459876 | PubMed |
| 21625331 | Expanding the Antimalarial Drug Arsenal-Now, But How? | Pharmaceuticals (Basel) | 2011 | https://conductscience.org/library/papers/21625331 | PubMed |
| 20846404 | CPP-ZFN: a potential DNA-targeting anti-malarial drug. | Malar J | 2010 | https://conductscience.org/library/papers/20846404 | PubMed |
| 18672017 | Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge. | Vaccine | 2008 | https://conductscience.org/library/papers/18672017 | PubMed |
| 18582108 | Influence of DNA structure on adjacent site cooperative binding. | J Phys Chem B | 2008 | https://conductscience.org/library/papers/18582108 | PubMed |
| 18174336 | Chemical attenuation of Plasmodium berghei sporozoites induces sterile immunity in mice. | Infect Immun | 2008 | https://conductscience.org/library/papers/18174336 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17524501
GET https://conductscience.org/api/papers/v1/17524501/authors